Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Stimulants01:29

Stimulants

178
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
178
Drug Dependence01:17

Drug Dependence

992
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
992
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

207
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
207
Clinical Trials01:16

Clinical Trials

6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

E-cigarette use in vehicles: factors associated with secondhand exposure and behaviour from a US young adult sample in 2024.

Tobacco control·2026
Same author

Bridging the Hospital Discharge Gap: Pilot Trial of a Digital Smoking Cessation Program for Psychiatric Inpatients.

Psychiatric services (Washington, D.C.)·2026
Same author

Cigarette smoking in PrEP recipients: a challenge and an opportunity.

The lancet. HIV·2026
Same author

From use cases to infrastructure: a cross-institutional survey of priorities in data-driven biomedical research.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Geographic Representativeness of a Digital Tobacco Cessation Intervention: An Exploration of Changes in Rural Reach From 2013-2020.

Tobacco use insights·2025
Same author

Does the timing of sample collection confound the association between prenatal serum PFAS concentrations and birthweight: results from two prospective cohort studies.

Environment international·2025
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026
Same journal

HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

JAMA·2026
Same journal

US Dietary Supplement Use Increasing, Especially in Older Adults.

JAMA·2026
Same journal

Heat Stress From Climate Change Surges Globally.

JAMA·2026
Same journal

Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

JAMA·2026
関連記事をすべて見る

関連する実験動画

Updated: Jun 17, 2025

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.3K

電子タバコを吸う青少年向け 禁煙メールプログラム ランダム化臨床試験

Amanda L Graham1,2,3, Sarah Cha1, Megan A Jacobs1

  • 1Innovations Center, Truth Initiative, Washington, DC.

JAMA
|August 7, 2024
PubMed
まとめ
この要約は機械生成です。

テキスト・メッセージ・プログラムが 十代の若者が 電子タバコをやめることを 有効に助けました この介入により 禁煙率がコントロール群と比較して 大きく上昇し 青少年のニコチン戒断に 新しいツールが提供されました

さらに関連する動画

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

25.4K
Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

11.5K

関連する実験動画

Last Updated: Jun 17, 2025

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.3K
Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

25.4K
Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

11.5K

科学分野:

  • 公衆衛生
  • 青少年 の 健康
  • デジタルヘルスの介入

背景:

  • 電子タバコは 青少年の中で 最も普及しているタバコ製品です
  • 青春期 に ニコチン に 曝露 さ れる の は,健康 に 大きな 危険 を もたらし ます.
  • 経験的に検証されたティーンエイジャーの 禁煙対策は不足しています

研究 の 目的:

  • 青少年のニコチン使用停止のためのテキストメッセージベースのプログラムの有効性を評価する.
  • 介入グループと評価のみの対照群の間で,電子タバコの禁煙率を比較する.

主な方法:

  • 平行グループ,ダブルブラインド,個別ランダム化臨床試験が行われました.
  • 参加者は (13歳から17歳) ソーシャルメディアを通じて募集され,テキストメッセージの禁酒プログラムまたは評価のみを受けるようにランダムに割り当てられました.
  • 1ヶ月と7ヶ月でテキストメッセージ,オンライン,または電話で停止評価を行った.

主要な成果:

  • 平均年齢は16. 4歳でした.
  • 7ヶ月のフォローアップで,ポイント・プレヴァレンスの禁酒率は介入群で37. 8%と対照群で28. 0%であった.
  • この介入により,電子タバコの禁煙が統計的に有意に増加した (RR,1. 35; P < . 001).

結論:

  • インタラクティブなテキスト・メッセージによる介入は 青少年の自己報告による 禁煙を大幅に増加させました
  • ソーシャル・メディアによる採用による デジタル・ヘルス・アプローチは 青少年における 電子タバコの使用の対策に 有望な結果をもたらします
  • 喫煙をやめた若者の間で 燃焼性タバコ製品への移行を示唆する証拠はありません.